These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28431771)

  • 21. Response to Letter to the Editor submitted by Dr. Nick Chartres and Ms. Courtney Cooper: RE: A systematic review of adverse health effects associated with oral cadmium exposure, by Schaefer HR et al. Regul Toxicol Pharmacol. 2022; 134:105243.
    Schaefer HR; Flannery BM; Crosby LM; Jones-Dominic OE; Punzalan C; Middleton K
    Regul Toxicol Pharmacol; 2023 Jun; 141():105392. PubMed ID: 37087091
    [No Abstract]   [Full Text] [Related]  

  • 22. Predictivity of animal studies for human injection site reactions with parenteral drug products.
    Engelhardt JA
    Exp Toxicol Pathol; 2008 Aug; 60(4-5):323-7. PubMed ID: 18513931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corrigendum to "Low doses of arsenic, via perturbing p53, promotes tumorigenesis" [Toxicol. Appl. Pharmacol. (2016) 98-104].
    Ganapathy S; Li P; Fagman J; Yu T; Lafontant J; Zhang G; Chen C
    Toxicol Appl Pharmacol; 2017 Jan; 314():118. PubMed ID: 27851896
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to "The research of genetic toxicity of β-phellandrene" [Environ. Toxicol. Pharmacol. 54 (2017) 28-33].
    Cheng Z; Jiang J; Yang X; Chu H; Jin M; Li Y; Xi T; Wang S; Huang Y; Shang L; Wu S; Hao W; Qian Y; Wei X
    Environ Toxicol Pharmacol; 2018 Jul; 61():116. PubMed ID: 29853321
    [No Abstract]   [Full Text] [Related]  

  • 25. Corrigendum to "Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice" [Toxicol. Appl. Pharmacol. 316 (2017) 74-82].
    Choi YJ; Lee KY; Jung SH; Kim HS; Shim G; Kim MG; Oh YK; Oh SH; Jun DW; Lee BH
    Toxicol Appl Pharmacol; 2017 Apr; 320():73. PubMed ID: 28189653
    [No Abstract]   [Full Text] [Related]  

  • 26. Corrigendum to "Zearalenone impairs the male reproductive system functions via inducing structural and functional alterations of sertoli cells" [Environ. Toxicol. Pharmacol. 42 (2016) 146-155].
    Zheng W; Pan S; Wang G; Wang YJ; Liu Q; Gu J; Yuan Y; Liu XZ; Liu ZP; Bian JC
    Environ Toxicol Pharmacol; 2016 Jun; 44():158. PubMed ID: 27117453
    [No Abstract]   [Full Text] [Related]  

  • 27. Corrigendum to "Differential effects of the persistent DDT metabolite methylsulfonyl-DDE in nonstimulated and LH-stimulated neonatal porcine Leydig cells" [Toxicol. Appl. Pharmacol. 267 (2013) 247-255].
    Castellanos CG; Sørvik IB; Tanum MB; Verhaegen S; Brandt I; Ropstad E
    Toxicol Appl Pharmacol; 2017 Oct; 332():159-160. PubMed ID: 28522354
    [No Abstract]   [Full Text] [Related]  

  • 28. Corrigendum to "Use of a combined effect model approach for discriminating between ABCB1- and ABCC1-type efflux activities in native bivalve gill tissue" [Toxicol. Appl. Pharmacol. (2016) 56-67].
    Faria M; Pavlichenko V; Burkhardt-Medicke K; Soares AMVM; Altenburger R; Barata C; Luckenbach T
    Toxicol Appl Pharmacol; 2016 Jul; 303():110. PubMed ID: 27157384
    [No Abstract]   [Full Text] [Related]  

  • 29. Corrigendum to "Effect of probiotic supplement on aflatoxicosis and gene expression in the liver of broiler chicken" [Environ. Toxicol. Pharmacol. 60 (2018) 118-127].
    Salem R; El-Habashi N; Fadl SE; Sakr OA; Elbialy ZI
    Environ Toxicol Pharmacol; 2018 Sep; 62():244. PubMed ID: 30111499
    [No Abstract]   [Full Text] [Related]  

  • 30. Corrigendum to Stage-specific metabolic features of differentiating neurons: Implications for toxicant sensitivity Toxicol Appl Pharmacol, 354 (2018) 64-80.
    Delp J; Gutbier S; Cerff M; Zasada C; Niedenführ S; Zhao L; Smirnova L; Hartung T; Borlinghaus H; Schreiber F; Bergemann J; Gätgens J; Beyss M; Azzouzi S; Waldmann T; Kempa S; Nöh K; Leist M
    Toxicol Appl Pharmacol; 2019 Jun; 372():70. PubMed ID: 31002859
    [No Abstract]   [Full Text] [Related]  

  • 31. Corrigendum to 'Embryotoxic and pharmacologic potency ranking of six azoles in the rat whole embryo culture by morphological and transcriptomic analysis' [Toxicol. Appl. Pharmacol., 322 (2017) 15-26].
    Dimopoulou M; Verhoef A; Pennings J; van Ravenzwaay B; Rietjens IMCM; Piersma AH
    Toxicol Appl Pharmacol; 2018 Sep; 355():287. PubMed ID: 29980297
    [No Abstract]   [Full Text] [Related]  

  • 32. Corrigendum to "MWCNTs of different physicochemical properties cause similar inflammatory responses, but differences in transcriptional and histological markers of fibrosis in mouse lungs" [Toxicol. Appl. Pharmacol., 284 (2015) 16-32].
    Poulsen SS; Saber AT; Williams A; Andersen O; Købler C; Atluri R; Pozzebon ME; Mucelli SP; Simion M; Rickerby D; Mortensen A; Jackson P; Kyjovska ZO; Mølhave K; Jacobsen NR; Jensen KA; Yauk CL; Wallin H; Halappanavar S; Vogel U
    Toxicol Appl Pharmacol; 2018 Sep; 355():286. PubMed ID: 29908758
    [No Abstract]   [Full Text] [Related]  

  • 33. Corrigendum to "Arsenic cardiotoxicity: An overview" [Environ. Toxicol. Pharmacol. 40 (2015) 1005-1014].
    Alamolhodaei NS; Shirani K; Karimi G
    Environ Toxicol Pharmacol; 2021 Feb; 82():103539. PubMed ID: 33199196
    [No Abstract]   [Full Text] [Related]  

  • 34. Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis "Toxicol Appl Pharmacol. 2016;305:194-202".
    Lin CF; Huang HL; Peng CY; Lee YC; Wang HP; Teng CM; Pan SL
    Toxicol Appl Pharmacol; 2020 Jan; 387():114858. PubMed ID: 31843362
    [No Abstract]   [Full Text] [Related]  

  • 35. Corrigendum to "The probable roles of valsartan in alleviating chronic obstructive pulmonary disease following co-exposure to cold stress and fine particulate matter" [Environ. Toxicol. Pharmacol. 60 (2018) 230-236].
    Liu J; Guo L; Zhang K; Song Q; Wei Q; Bian Q; Liang T; Niu J; Luo B
    Environ Toxicol Pharmacol; 2019 Aug; 70():103188. PubMed ID: 31126863
    [No Abstract]   [Full Text] [Related]  

  • 36. Corrigendum to "Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition" [Toxicol Appl Pharmacol 360 (2018) 1-8].
    Liu YR; Sun B; Zhu GH; Li WW; Tian YX; Wang LM; Zong SM; Sheng PZ; Li M; Chen S; Qin Y; Liu HJ; Zhou HG; Sun T; Yang C
    Toxicol Appl Pharmacol; 2022 Jan; 435():115824. PubMed ID: 34890639
    [No Abstract]   [Full Text] [Related]  

  • 37. Corrigendum to "Immunotoxicity and biodistribution analysis of arsenic trioxide in C57B1/6 mice following a 2-week inhalation exposure": [Toxicol. Appl. Pharmacol. 241 (2009) 253-259].
    Burchiel SW; Mitchell LA; Lauer FT; Sun X; McDonald JD; Hudson LG; Liu KJ
    Toxicol Appl Pharmacol; 2010 Aug; 246(3):188. PubMed ID: 21103386
    [No Abstract]   [Full Text] [Related]  

  • 38. Corrigendum to "Astrocyte activation and neurotoxicity: A study in different rat brain regions and in rat C6 astroglial cells" [Environ. Toxicol. Pharmacol. 40 (2015) 122-139].
    Goswami P; Gupta S; Joshi N; Sharma S; Singh S
    Environ Toxicol Pharmacol; 2022 Jan; 89():103758. PubMed ID: 34776397
    [No Abstract]   [Full Text] [Related]  

  • 39. Corrigendum to "A time-course investigation of the human urinary excretion of the hydrogen sulfide biomarker trimethylsulfonium" [Environ. Toxicol. Pharmacol. 100 (2023) 104162].
    Lajin B; Obermayer-Pietsch B; Somma R; Goessler W
    Environ Toxicol Pharmacol; 2023 Nov; 104():104296. PubMed ID: 37839941
    [No Abstract]   [Full Text] [Related]  

  • 40. Corrigendum to "Phenolic acid protects of renal damage induced by ochratoxin A in a 28-days-oral treatment in rats" [Environ. Toxicol. Pharmacol. 43 (2016) 105-111].
    Cariddi LN; Escobar FM; Sabini MC; Campra NA; Bagnis G; Decote-Ricardo D; Freire-de-Lima CG; Mañas F; Sabini LI; Dalcero AM
    Environ Toxicol Pharmacol; 2016 Jun; ():. PubMed ID: 27262723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.